Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-02

Clinical Trial Update: Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing diosmin with cabergoline for prevention of ovarian hyperstimulation syndrome in infertility completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)
  • Diosmin (Diosmin)

Snippet

Sponsor: Benha University | Conditions: Infertility | Phase 2, Phase 3 | Status: COMPLETED